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IN THIS ISSUE 
Requisition of Keratinocyte Proliferation . . . 
Keratinocyte stem cells are thought to be among the more slowly 
proliferating basal cells located in proximity to epidennal Langer-
hans cells (ECLs). Based on this observation, Potten and Allen hy-
pothesized nearly twenty years ago that ECLs might regulate these 
stem cells. Until now there has been no molecular evidence to 
support this idea. In this issue, Parkinson et al (p. 113) describe the 
tissue specificity of the newly identified hematopoietic stem cell 
inhibitor/macrophage inflammatory protein la (SClfMIP-la). 
Their emphasis is placed on identification of cells that produce the 
cytokine as well as its influence on the proliferative response of 
keratinocytes. This study provides the first evidence that "ECLs 
regulate the keratinocyte cell cycle by the production of an inhibitor 
of keratinocyte proliferation." 
SCI/MIP-1a is a potent reversible inhibitor of keratinocyte pro-
liferation as measured by its effect on plating and cloning efficien-
cies as well as on growth rates of cultured human and mouse kerati-
nocytes. It is not, however, produced by the keratinocytes 
themselves as are other keratinocyte proliferation inhibitors such as 
transforming growth factor p, tumor necrosis factor, and interferon. 
The only epidermal cell type to contain detectable SCI/MIP-1a 
transcripts is ECLs, which are hematopoietic in origin. Thus, SClf 
MIP-la is the first cytokine shown to operate by a paracrine mecha-
nism within the skin. This group proposes a mechanism for control 
of epidermal cell proliferation in which "the ECL acts as the source 
of a potent reversible inhibitory molecule that is produced in the 
locale of the stem cells and may be maintained in this restricted area 
by virtue of its tendency to bind proteoglycan residues." SCI/MIP-
1a could be involved ill vivo in keratinocyte homeostasis as well as in 
hyperproliferation in wound repair, psoriasis, cancer, and other skin 
disorders. Furthermore, interleukin-8, a closely related chemokine, 
stimulates epidermal cell proliferation and may act to balance the 
effects of the inhibitor. 
. . . And Keratinocyte Differentiation. 
Along their maturation pathway from the basal layer to the stratum 
corneum, epidermal keratinocytes undergo a series of morphologic 
and biochemical changes. One of the later events, in cells of the 
granular layer and lower stratum corneum, is the appearance of 
keratohyalin granules resulting from transcription and production 
of a newrrotein, profilaggrin. This large precursor contains many 
repeats 0 filaggrin, which causes aggregation of intermediate fila-
ments ;'1 ,litro and is thought to be involved in alignment of keratin 
bundles for interfilament disulfide cross-linking in "ivo. Later, in the 
upper stratum corneum, filaggrin is broken down to component 
amino acids, which may help to bind water molecules in the upper 
stratum corneum. Cultured keratinocytes express many of the bio-
chemical markers of epidermal differentiation, including profilag-
grin, once the cells reach confluence and overall protein synthesis 
decreases. 
Ichthyosis vulgaris is an autosomal dominant inherited scaling 
disorder of the skin. Keratohyalin granules, profilaggrin, and fi lag-
grin are reduced or absent in biopsies or keratinocyte cultures from 
affected individuals. In one model of this disorder, reduced levels of 
filaggrin cause decreased water retention by amino acids in the 
stratum corneum, and "dry" skin results. Haydock and co-workers 
(p. 118) present a study in this issue that tests this hypothesis by 
using "anti-sense technology" to inhibit profilaggrin production 
and produce the ichthyosis vulgaris phenotype in cultured keratino-
cytes. Transformation with a plasmid that produces an RNA tran-
script complementary to profilaggrin mRNA causes inactivation of 
the message and inhibition of the synthesis of profilaggrin. As pre-
dicted, keratohyalin granules were reduced and cell keratinocyte 
morphology was abnormal. However, other morphologic and bio-
chemical disturbances, including a delay in the decrease of protein 
synthesis associated with confluence, were found . These results 
suggest an additional, more global effect of profilaggrin on in vitro 
epidermal differentiation and demonstrate the utility of anti-sense 
technology in keratinocyte biology. 
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Anti-Sense Tips the Scales of Psoriasis Toward Macrophages 
The most obvious clinical and histologic aspects of psoriasis are 1) 
an increase in the number of proliferating cells in the basal epider-
mis, which leads to scaly, plaque-like lesions, and 2) an inflamma-
tory infiltrate that causes their erythematous appearance. The pres-
ence of infiltrating lymphocytes has suggested the involvement of 
immunologic processes in the pathogenesis of psoriasis. Lympho-
cytes and neutrophils that immigrate into the epidermis have been 
the focus of most studies. In this issue Gillitzer et af (p. 127) examine 
a population of potentially mobile population of CD68+ macro-
phages and demonstrate that the "dermal macrophages are accumu-
lated in the subepidermal space ... often aligned along the tips of 
elongated rete ridges like pearls." They asked, "What are the solu-
ble signals that contribute to this restricted distribution of dermal 
macrophages?" and "Is there a functional interrelationship between 
dermal macrophages and the highly proliferative basal keratino-
cytes in psoriasis?" In situ hybridization of anti-sense 35S-RNA 
probes for the potent monocyte chemotactic protein-1 (Mep-1) 
detected mRNA in scattered cells within the suberidermal srace 
and "most surprisingly, in the basal keratinocytes 0 the tips 0 the 
rete ridges of psoriatic lesions. Thereby, every keratinocyte in a row 
expresses high levels of MCP-1 [and] a specific gradient is created 
between the basal layer and the dermal compartment." Dermal 
macrophages may recognize this gradient. The restricted location of 
MCP-1 correlates with high rate of proliferation in the keratmo-
cytes expressing MCP-1 message and with the location of macro-
phages on the dermal side of the basement membrane near. the r.ete 
pegs. The authors suggest "there is a dialogue between prohferatmg 
basal keratinocytes and dermal macrophages with MCP-1 as one of 
the communicating signals." 
Becoming Sensitive to Hapten Dosage 
Since the early 1970s most cutaneous antigen presenting function 
has been attributed to epidermal Langerhans cells. Recently, B. 
Nickoloff,J.W. Streilein, and K. Cooper (among others) suggested 
that non-Langerhans dermal cells derived from the bone marrow 
also may function as antigen-presenting cells (APC), particularly 
after exposure of the skin to ultraviolet B (UVB) radiation. The 
question may hinge in part on the amount of hapten applied to the 
skin to sensitize the mice. In this issue, Kurimoto and Streilein (p. 
132) have determined a so-called "optimized sensitizing dose" of 
dinitrofluorobenzene for UVB-susceptible and UVB-resistant 
strains of mice. Their results indicate that when conventional (high) 
sensitizing doses of hapten were used, both epidermal and dermal 
antigen presenting cells participated in the induction of contact 
hypersensitivity. However, with optimal epicutaneous sensitizing 
doses of antigen, only epidermal Langerhans cells contributed to the 
response. 
When mouse skin was irradiated with UVB sufficient to obliter-
ate epidermal Langerhans celis, conventional doses of hapten in-
duced sensitivity in UVB-resistant but not UVB-susceptible strains, 
probably because dermal APC were missing or nonfunctional in the 
UVB-susceptible mice. In contrast, with the optimal sensitizing 
dose the authors were not able to sensitize by the epicutaneous route 
either UVB-resistant or UVB-susceptible strains of mice. Intracuta-
neous sensitization with this same optimal dose of hapten, however, 
produced sensitization in the UVB-resistant but not in the l.!VB-
susceptible strains, demonstrating that the APC in the dermiS re-
mained functional in the UVB-resistant but not in the UVB-
susceptible mice. At a lower dose of UV that altered morphology 
but did not eliminate Langerhans celis, epicutaneous application 
produced sensitivity in UVB-resistant but not in UVB-susceptible 
strains. 
These results imply that the dose and means of delivery of the 
sensitizing hapten determine whether cells of the epidermis or 
dermis (or both) provide antigen presenting function and that Lan-
gerhans celis are not necessary for intracutaneous sensitization. Fur-
thermore, since little UVB actually penetrated the dermis, and since 
UVB-irradiated mice still provide APC function, failure of the der-
mal response in UVB-susceptible mice "suggests that factors re-
leased from UVB-damaged epidermis diffuse into the dennis and 
suppress local APC function." Tumor necrosis factor a, cis-urocan.i.c 
acid, and DNA excision and repair enzymes are among the elements 
that may mediate this response. 
Hot Spots and Blistering 
Some forms of epidermolysis bullosa are manifested in keratinocytes 
and involve abnormalities in the assembly of keratin filaments. The 
"simplex" class (EBS) is the mildest form and shows characteristic 
blistering in the epidermis, healing without scarring, basal celi cy-
tolysis, and autosomal dominant inheritance of alterations in the 
keratin 5 and keratin 14 genes. Sporadic cases ofEBS have also been 
diagnosed. The severity of the disorder may be related to the site of 
mutation within the keratin protein. 
Some regions of genes are more likely to undergo mutation than 
others, so that many mutations may be found to be localized to these 
regions, which are called "hot spots". A major goal in understand-
ing the molecular basis of any genetic disorder is a correlation be-
tween a particular mutation, the structure of the affected gene prod-
uct, and the severity of the disorder. In this issue, Stephens et al (p. 
240) report the occurrence of a hot spot in codon 125 of keratin 14 
with genetic linkage to the Dowling-Meara subtype of EBS. This 
vari.ant of EBA displays distinctive clumps of keratin filaments by 
electron microscopy. This is an important mutation because there 
may be extensive involvement of affected individuals at birth, and 
affected infants may die. Since 50% of the cases ofEBS-DM studied 
carried mutations in codon 125, the authors recommend DNA-
based prenatal diagnosis in families with EBS-DM. The reason for 
the high level of mutability of this region is unknown, but now that 
the hot spot has been identified, this question may be asked. 
